Blood cancer patients who may have previously struggled to find a donor for transplantation now have more options. A new study shows that patients achieve good outcomes with a partial match drawn from ...

BUFFALO, N.Y. (WIVB) — A new approach regarding stem-cell transplants has resulted in “exceptionally high” one-year overall ...

Stem cell transplantation (or bone marrow transplantation) and gene therapy have revolutionized the way oncologists treat ...

HLA compatibility is considered the key criterion for selecting donors for allo-HSCT. DKMS study data presented at the DGHO Annual Meeting 2025 in Cologne indicate the biological age of donors has a ...

New York center hits survival with a 92.6% one-year rate for first-time allogeneic stem cell transplants, surpassing national benchmarks.

The selection of suitable donors is crucial for the long-term recovery of patients after an allogeneic hematopoietic stem cell transplantation (allo-HSCT). Primarily, the transplantation from a ...

Roswell Park reports a 92.6% one-year survival rate for first-time allogeneic stem cell transplants after standardizing ...

Allogeneic HSCT achieved 92% sustained, medication-free remission and 100% survival in children with monogenic IBD, highlighting its potential as a transformative treatment. Monogenic IBD, ...

Phase I clinical trial results suggest that an antibody treatment, used in combination with other drugs, enabled stem cell transplants for three children with Fanconi anemia without toxic busulfan ...

For patients with newly diagnosed multiple myeloma not undergoing an autologous stem cell transplant, indefinite lenalidomide ...

Children who survive a stem-cell transplant only to watch their own donor cells attack their organs now have a ...